Immune-modulating medication may help clear HIV reservoir
Injectable HIV treatment unlikely to be arriving soon in the global south
Adherence counselling reverses viral rebound on dolutegravir in 95% of cases
What’s happened to services for key populations in Uganda following the Anti-Homosexuality Act?
Two modelling studies ask: will injectable PrEP ever be cost-effective at achievable prices?
People with HIV are not at greater risk for severe mpox unless they are immunosuppressed
Here is what transgender women across Asia want in PrEP
People with HIV remain at higher risk of dying from COVID-19 in the Omicron era
Integrase inhibitors raise the risk of diabetes regardless of weight gain
A perfect storm for stigma: gay and bisexual men’s experiences of mpox
Oral lenacapavir can bridge gaps if injections must be missed
Switches away from integrase inhibitors do not reverse weight gain, studies find
Social network intervention increases HIV self-testing among African fishermen by 50%
At-home support after HIV diagnosis in Uganda helps people get on ART and stick with it
Coercive reproductive healthcare practices reported by many women living with HIV
Statins and HIV: how can the REPRIEVE findings be implemented in the real world?
Diagnosis and treatment for high blood pressure need to be funded as part of HIV treatment programmes
Bictegravir safe and effective in pregnancy
